United States — Food and Drug Administration & Lawrence Rosen
9 shared events · Importance 6 · Last updated May 12, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Disc Medicine, Inc. for its bitopertin program, citing uncertainties in the new drug application.
Lawrence Rosen: Lawrence Rosen is a founding partner of Rosen Law Firm, which is investigating Disc Medicine, Inc. for securities claims.
May 01, 2026 · 6 articles
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration's potential non-approval of tabelecleucel's Biologics License Application due to manufacturing issues is a key factor in the lawsuit against Atara Biotherapeutics.
Lawrence Rosen: Lawrence Rosen is a founding partner of Rosen Law Firm, which is pursuing a class action lawsuit against Atara Biotherapeutics.
Apr 01, 2026 · 58 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and Lawrence Rosen interact across events, view sentiment trends, and discover connected entities.
Open Dashboard